KRON Archived Articles

Kronos Bio, Inc. (NASDAQ:KRON): Navigating Choppy Waters with Strategic Realignment


Kronos Bio's Strategic Shift Amid Clinical Setbacks


Kronos Bio, Inc. (NASDAQ:KRON): Targeting Deregulated Transcription in Cancer with Promising Pipeline